Publicacións (221) Publicacións nas que participase algún/ha investigador/a

2019

  1. 5-HT 2 receptor binding, functional activity and selectivity in N-benzyltryptamines

    PLoS ONE, Vol. 14, Núm. 1

  2. 2-Aryladenine derivatives as a potent scaffold for A1, A3 and dual A1/A3 adenosine receptor antagonists: Synthesis and structure-activity relationships

    Bioorganic and Medicinal Chemistry, Vol. 27, Núm. 16, pp. 3551-3558

  3. A 3D Printed Patient-specific Simulator for Percutaneous Coronary Intervention

    Revista Espanola de Cardiologia, Vol. 72, Núm. 5, pp. 424-426

  4. A Bio-inspired Hypoxia Sensor using HIF1a-Oxygen-Dependent Degradation Domain

    Scientific Reports, Vol. 9, Núm. 1

  5. A Combination of Proteomic Approaches Identifies A Panel of Circulating Extracellular Vesicle Proteins Related to the Risk of Suffering Cardiovascular Disease in Obese Patients

    Proteomics, Vol. 19, Núm. 1-2

  6. A New Model of Sensorial Neuron-Like Cells for HTS of Novel Analgesics for Neuropathic Pain

    SLAS Discovery, Vol. 24, Núm. 2, pp. 158-168

  7. A Novel Calsequestrin 2 Deletion Causing Catecholaminergic Polymorphic Ventricular Tachycardia and Sudden Cardiac Death

    Revista Espanola de Cardiologia, Vol. 72, Núm. 8, pp. 681-683

  8. A SimSET-STIR hybrid Monte Carlo model for the Philips Vereos Digital PET

    2019 IEEE Nuclear Science Symposium and Medical Imaging Conference, NSS/MIC 2019

  9. A community intervention study on patients’ resuscitation and defibrillation quality after embedded training in a cardiac rehabilitation program

    Health Education Research, Vol. 34, Núm. 3, pp. 289-299

  10. A de novo heterozygous missense BSCL2 variant in 2 siblings with intractable developmental and epileptic encephalopathy

    Seizure, Vol. 71, pp. 161-165

  11. A multifunctional drug nanocarrier for efficient anticancer therapy

    Journal of Controlled Release, Vol. 294, pp. 154-164

  12. A novel low molecular weight nanocomposite hydrogel formulation for intra-tumoural delivery of anti-cancer drugs

    International Journal of Pharmaceutics, Vol. 565, pp. 151-161

  13. A prospective study of the clinical outcomes and prognosis associated with comorbid COPD in the atrial fibrillation population

    International Journal of COPD, Vol. 14, pp. 371-380

  14. AMPA receptor GluA2 subunit defects are a cause of neurodevelopmental disorders

    Nature Communications, Vol. 10, Núm. 1

  15. ANGPTL-4 is associated with obesity and lipid profile in children and adolescents

    Nutrients, Vol. 11, Núm. 6

  16. ATP-based therapy prevents vascular calcification and extends longevity in a mouse model of Hutchinson–Gilford progeria syndrome

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 116, Núm. 47, pp. 23698-23704

  17. Ablation of atrial fibrillation in patients with Brugada syndrome: A systematic review of the literature

    Journal of Arrhythmia, Vol. 35, Núm. 1, pp. 18-24

  18. Acute myocardial infarction complicated with cardiogenic shock as a late onset of Kawasaki disease

    Revista Portuguesa de Cardiologia, Vol. 38, Núm. 2, pp. 161-162

  19. Addition of IMP3 to L1CAM for discrimination between low- and high-grade endometrial carcinomas: a European Network for Individualised Treatment of Endometrial Cancer collaboration study

    Human Pathology, Vol. 89, pp. 90-98

  20. Adipocyte MTERF4 regulates non-shivering adaptive thermogenesis and sympathetic-dependent glucose homeostasis

    Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1865, Núm. 6, pp. 1298-1312